鎮痛薬の市場規模、シェア、動向分析レポート：薬物タイプ別、投与経路別、用途別、流通チャネル別、地域別、セグメント予測、2023年～2030年

鎮痛薬市場の成長と動向

GrandView Research, Inc.の最新レポートによると、世界の鎮痛剤市場規模は2030年までに613億9,000万米ドルに達する見込みです。

また、予測期間中のCAGRは6.02%で拡大する見込みです。この成長は、慢性疾患の有病率の上昇と世界の老年人口の急増に支えられています。さらに、革新的な鎮痛薬の規制当局による承認が進んでいること、研究開発活動が活発化していることも、市場成長に寄与するその他の主な要因です。例えば、米国FDAは2021年10月、成人患者の急性疼痛管理にトラマドールとセレコキシブを含む配合錠剤を承認しました。

慢性および急性の疼痛症状の増加は、鎮痛薬市場に有利な成長機会をもたらすと期待されています。例えば、2021年4月、国際疼痛学会によると、米国では5,020万人以上の成人が毎日痛みを訴えており、最も一般的なタイプは膝、腰、足の痛みです。これらの症状に対して処方される一般的な鎮痛剤には、フェンタニル、コデイン、アセトアミノフェン、セレコキシブなどのNSAIDsがあります。

さらに、世界の老年人口の急増により慢性疾患の有病率が増加することが予想され、これが鎮痛薬市場の成長を促進すると期待されています。米国国勢調査局によると、米国には65歳以上の成人が5,400万人以上居住しています。老年人口は、がん、心血管障害、筋骨格系疾患などの慢性疾患にかかりやすく、これらの疾患に伴う疼痛も多いです。さらに、NIHによると、老年人口における慢性神経障害性疼痛の有病率は10～52％です。

患者のコンプライアンスを高め、既存の治療薬の安全性を向上させるための新薬の設計・開拓の進歩が、市場の成長を促進しています。例えば、ナプロキセン、Voltaren-XR（ジクロフェナク）、トラマドールなどの鎮痛薬は、徐放性錠剤として販売されています。サン・ファーマシューティカル・インダストリーズ社のVolini Maxxスプレーやバイエル社のAleveXスプレーは、散布制御を向上させ、乱れや垂れ落ちをなくしたターゲット・スプレー技術の一例です。これらの製品の採用増加は、筋骨格系用途での市場成長を促進すると予想されます。

鎮痛薬とオピオイド鎮痛薬の併用は、その高い有効性から需要が増加しており、市場関係者の新規かつ効果的な疼痛管理薬の開発意欲を高めています。例えば、2022年には、米国で治療困難な疼痛症状に対して第3相臨床試験中のCBDとTHCの新規分子が8つあっています。

さらに、大手企業による提携、新製品の上市、共同開発など、さまざまな展開も市場成長の要因となっています。例えば、2021年8月、Alkem Laboratories社は、変形性関節症および関節リウマチの症状管理のためのファモチジンとイブプロフェンの錠剤を米国で発売すると発表しました。

さらに2020年12月には、ノバルティスの一部門であるサンドが、米国でアセトアミノフェン・ジェネリック注射剤の即時発売を発表しました。この注射剤は、成人および小児患者の軽度から中等度の疼痛管理に使用されます。さらに、鎮痛剤の副作用を軽減するための配合剤が承認されつつあることも、今後数年間の鎮痛剤市場の成長を高めると予想されます。

鎮痛薬市場レポートハイライト

• オピオイド鎮痛薬よりも副作用が少なく、薬物依存を発症する可能性が低いことから、非オピオイド薬タイプセグメントが2022年に最大の市場シェアを占める
• 投与経路別では、薬剤投与に特別な器具を必要とせず、患者のコンプライアンスも高い経口投与が鎮痛薬市場を独占
• 外科・外傷領域は、基準年の売上貢献の上位を占めたが、これは世界的に毎年非常に多くの手術が行われていることに起因しています。
• オンライン薬局部門は、遠隔医療導入の増加と医療品販売のためのeコマースサイトの出現により、最も速い成長率を示すと予想されます。
• アジア太平洋地域は、大手メーカー投資の増加やアンメット・メディカル・ニーズの高まりにより、予測期間中に最も速い成長が見込まれます。

目次

第1章 調査手法

• 市場セグメンテーションと範囲
  • セグメントの定義
• 地域の範囲
• 推定・予測のタイムライン
• 目的
• 調査手法
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
• 二次情報のリスト
• 略語のリスト

第2章 エグゼクティブサマリー

• 市場概要
• セグメントのスナップショット
• 競合情勢

第3章 世界の鎮痛薬市場の変数、動向、および範囲

• 鎮痛剤市場の系統展望
  • 親市場の見通し
• 普及と成長の見通しのマッピング
• 市場促進要因の分析
  • 慢性疾患の有病率の増加
  • 高齢者人口の急増
  • 市販鎮痛剤の需要の高まり
• 市場抑制要因分析
  • 鎮痛剤の長期使用に伴う副作用
  • オポイド鎮痛薬の乱用の増加
• ポーターのファイブフォース分析
• SWOT分析
• COVID-19症の影響分析

第4章 鎮痛薬市場- 医薬品タイプ別セグメント分析、2018～2030年

• 世界の鎮痛剤市場：薬剤タイプの変動分析
• オピオイド
• 非オピオイド
• 複合薬剤

第5章 鎮痛薬市場- 投与経路別セグメント分析、2018～2030年

• 世界の鎮痛剤市場：投与変動分析
• 経口
• 非経口
• 経皮
• その他

第6章 鎮痛剤市場- 流通チャネル別セグメント分析、2018～2030年

• 鎮痛剤市場：流通チャネルの変動分析
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 鎮痛剤市場- 用途別セグメント分析、2018～2030年

• 鎮痛剤市場：用途変動分析
• 筋骨格系
• 手術と外傷
• がん
• 神経障害性
• 片頭痛
• 産科
• 線維筋痛症
• 熱傷の痛み
• 歯科/フェイシャル
• 小児
• その他

第8章 鎮痛薬市場- 地域別セグメント分析、2018～2030年

• 鎮痛剤市場：地域変動分析
• 北米
  • SWOT分析
  • 米国
  • カナダ
• 欧州
  • SWOT分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
  • その他
• アジア太平洋地域
  • SWOT分析
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
  • その他
• ラテンアメリカ
  • SWOT分析
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他
• 中東およびアフリカ（MEA）
  • SWOT分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート
  • その他

第9章 競合情勢

• 企業プロファイル
  • Bayer AG
  • Endo International plc
  • Assertio Holdings, Inc.
  • Janssen Global Services, LLC
  • GSK plc
  • AbbVie Inc
  • Novartis AG
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
• 戦略マッピング
  • 拡張
  • 買収
  • コラボレーション
  • 製品/サービスの発売
  • パートナーシップ
  • その他
• 企業の市場シェア分析、2022年
• 企業のポジション分析、2022
• 市場参入企業の分類

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Leading Market Players Anticipated to Witness Highest Growth
• Table 4 Global Analgesics Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 6 Global Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 7 Global Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 8 Global Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 9 North America Analgesics Market, By Country, 2018 - 2030 (USD Million)
• Table 10 North America Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 11 North America Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 12 North America Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 13 North America Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 14 U.S. Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 15 U.S. Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 16 U.S. Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 17 U.S. Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 18 Canada Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 19 Canada Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 20 Canada Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 21 Canada Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 22 Europe Analgesics Market, By Country, 2018 - 2030 (USD Million)
• Table 23 Europe Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 24 Europe Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 25 Europe Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 26 Europe Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 27 Germany Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 28 Germany Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 29 Germany Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 30 Germany Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 31 UK Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 32 UK Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 33 UK Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 34 UK Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 35 France Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 36 France Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 37 France Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 38 France Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 39 Spain Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 40 Spain Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 41 Spain Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 42 Spain Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 43 Italy Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 44 Italy Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 45 Italy Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 46 Italy Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 47 Denmark Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 48 Denmark Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 49 Denmark Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 50 Denmark Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 51 Sweden Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 52 Sweden Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 53 Sweden Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 54 Sweden Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 55 Norway Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 56 Norway Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 57 Norway Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 58 Norway Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific Analgesics Market, By Country, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 64 Japan Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 65 Japan Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 66 Japan Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 67 Japan Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 68 China Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 69 China Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 70 China Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 71 China Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 72 India Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 73 India Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 74 India Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 75 India Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 76 South Korea Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 77 South Korea Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 78 South Korea Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 79 South Korea Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 80 Australia Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 81 Australia Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 82 Australia Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 83 Australia Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 84 Thailand Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 85 Thailand Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 86 Thailand Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 87 Thailand Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 88 Latin America Analgesics Market, By Country, 2018 - 2030 (USD Million)
• Table 89 Latin America Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 90 Latin America Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 91 Latin America Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 92 Latin America Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 93 Brazil Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 94 Brazil Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 95 Brazil Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 96 Brazil Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 97 Argentina Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 98 Argentina Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 99 Argentina Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 100 Argentina Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 101 Mexico Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 102 Mexico Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 103 Mexico Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 104 Mexico Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 105 Middle East and Africa Analgesics Market, By Country, 2018 - 2030 (USD Million)
• Table 106 Middle East and Africa Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 107 Middle East and Africa Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 108 Middle East and Africa Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 109 Middle East and Africa Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 110 South Africa Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 111 South Africa Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 112 South Africa Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 113 South Africa Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 117 Saudi Arabia Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 118 UAE Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 119 UAE Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 120 UAE Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 121 UAE Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 122 Kuwait Analgesics Market, By Drug Type, 2018 - 2030 (USD Million)
• Table 123 Kuwait Analgesics Market, By Route of Administration, 2018 - 2030 (USD Million)
• Table 124 Kuwait Analgesics Market, By Application, 2018 - 2030 (USD Million)
• Table 125 Kuwait Analgesics Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Analgesics market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2022)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Analgesics market: Drug type movement analysis
• Fig. 17 Analgesics market: Drug type segment dashboard
• Fig. 18 Analgesics market Drug type outlook: Key takeaways
• Fig. 19 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Non-opioids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Compound medication market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Analgesics market: Route of administration movement analysis
• Fig. 23 Analgesics market: Route of administration segment dashboard
• Fig. 24 Analgesics market Route of administration outlook: Key takeaways
• Fig. 25 Oral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Transdermal market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Analgesics market: Application movement analysis
• Fig. 30 Analgesics market: Application segment dashboard
• Fig. 31 Analgesics market Application outlook: Key takeaways
• Fig. 32 Musculoskeletal market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Surgical & trauma market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Neuropathic market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Migraine market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Obstetrical market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Fibromyalgia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Pain due to burns market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Dental/facial market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Analgesics market: Distribution channel movement analysis
• Fig. 44 Analgesics market: Distribution channel segment dashboard
• Fig. 45 Analgesics market Distribution channel outlook: Key takeaways
• Fig. 46 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Regional outlook, 2022 & 2030
• Fig. 50 Regional market dashboard
• Fig. 51 Regional market place: Key takeaways
• Fig. 52 North America, SWOT
• Fig. 53 Europe, SWOT
• Fig. 54 Asia Pacific, SWOT
• Fig. 55 Latin America, SWOT
• Fig. 56 Middle East and Africa, SWOT
• Fig. 57 North America
• Fig. 58 North America analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 U.S.
• Fig. 60 U.S. analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Canada
• Fig. 62 Canada analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Europe
• Fig. 64 Europe analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 UK
• Fig. 66 UK analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Germany
• Fig. 68 Germany analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Spain
• Fig. 70 Spain analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 France
• Fig. 72 France analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Italy
• Fig. 74 Italy analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Denmark
• Fig. 76 Denmark analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Sweden
• Fig. 78 Sweden analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 Norway
• Fig. 80 Norway analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Asia Pacific
• Fig. 82 Asia Pacific analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Japan
• Fig. 84 Japan analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 China
• Fig. 86 China analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 India
• Fig. 88 India analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 South Korea
• Fig. 90 South Korea analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Australia
• Fig. 92 Australia analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 Thailand
• Fig. 94 Thailand analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Latin America
• Fig. 96 Latin America analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 97 Brazil
• Fig. 98 Brazil analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Mexico
• Fig. 100 Mexico analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 101 Argentina
• Fig. 102 Argentina analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 103 Middle East and Africa
• Fig. 104 MEA analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 105 South Africa
• Fig. 106 South Africa analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 107 Saudi Arabia
• Fig. 108 Saudi Arabia analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 109 UAE
• Fig. 110 UAE analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 111 Kuwait
• Fig. 112 Kuwait analgesics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 113 Ansoff Matrix
• Fig. 114 Heat map analysis
• Fig. 115 Market differentiators

Analgesics Market Growth & Trends

The global analgesics market size is expected to reach USD 61.39 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the industry is expected to expand at a CAGR of 6.02% during the forecast period. The growth is aided by the rising prevalence of chronic disorders and the surge in the geriatric population globally. Moreover, ongoing regulatory approvals of innovative analgesics and increasing R&D activities are other key factors contributing to market growth. For instance, in October 2021, the U.S. FDA approved a combination pill containing tramadol and celecoxib for acute pain management in adult patients.

The increasing incidences of chronic and acute pain conditions are expected to offer lucrative growth opportunities in the market for analgesics. For instance, in April 2021, according to the International Association for the Study of Pain, over 50.2 million adults in the U.S. reported pain every day, with the most common types being knee, back, and foot pain. Some of the common analgesics prescribed for these conditions are fentanyl, codeine, and NSAIDs such as acetaminophen, celecoxib, and others.

In addition, the surge in the global geriatric population is expected to increase the prevalence of chronic diseases, which is expected to drive the market growth for analgesics. America's Health Rankings Senior Report 2021 states that according to the U.S. Census Bureau, more than 54 million adults aged 65 and above reside in the U.S. The geriatric population is more prone to chronic conditions such as cancer, cardiovascular disorders, musculoskeletal diseases, and associated pain with these diseases. Moreover, according to the NIH, the prevalence of chronic neuropathic pain in the geriatric population is 10-52%.

The advancements in the designing and development of novel drugs to boost patient compliance and improve the safety of existing therapeutics are driving the market growth forward. For instance, analgesics such as Naproxen, Voltaren-XR (diclofenac), and tramadol, among others, are available in extended-release tablet forms. Volini Maxx spray by Sun Pharmaceutical Industries Ltd. and Bayer's AleveX spray are examples of targeted spray technology for better spray control without mess and drip. Increasing adoption of these products is expected to drive market growth in musculoskeletal applications.

The increasing demand for combination analgesics and opioid analgesics due to their high efficacy is motivating market players to develop novel & effective pain management drugs. For instance, in 2022, there were eight new CBD and THC molecules in phase 3 clinical trials in the U.S. for difficult-to-treat pain conditions.

Furthermore, various developments such as partnerships, new product launches, and collaborations undertaken by leading players are other factors contributing to the market growth. For instance, in August 2021, Alkem Laboratories announced the launch of famotidine and ibuprofen tablets for the management of osteoarthritis and rheumatoid arthritis symptoms in the U.S.

In addition, in December 2020, Sandoz, a Novartis division, announced the immediate availability of acetaminophen generic injection in the U.S. This injection is used for the management of mild to moderate pain in adult as well as pediatric patients. Moreover, the growing approval of combination drugs to reduce the side effects of analgesics is further expected to increase the market growth for analgesics in the coming years.

Analgesics Market Report Highlights

• The non-opioid drug type segment held the largest market share in 2022, owing to lesser side effects than opioid analgesics and a lower chance of developing drug dependency
• Based on the route of administration, the oral segment dominated the market for analgesics due to the lack of requirement of any special apparatus for drug administration and high patient compliance for the oral route
• The surgical & trauma application segment was the leading revenue contributor during the base year, which is attributed to the significantly large number of surgeries performed globally every year
• The online pharmacies segment is anticipated to exhibit the fastest growth rate, owing to the increasing adoption of telemedicine and the emergence of several e-commerce sites to sell medical products
• Asia Pacific is expected to exhibit the fastest growth over the forecast period, due to rising investments in the region by major manufacturers and extensive unmet medical needs

Table of Contents

Chapter 1 Research Methodology

• 1.1 Market Segmentation & Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 Drug type segment
    • 1.1.1.2 Application segment
    • 1.1.1.3 Route of administration segment
    • 1.1.1.4 Distribution channel segment
• 1.2 Regional Scope
• 1.3 Estimates and Forecast Timeline
• 1.4 Objectives
  • 1.4.1 Objective - 1
  • 1.4.2 Objective - 2
  • 1.4.3 Objective - 3
• 1.5 Research Methodology
• 1.6 Information Procurement
  • 1.6.1 Purchased Database
  • 1.6.2 Gvr's Internal Database
  • 1.6.3 Secondary Sources
  • 1.6.4 Primary Research
  • 1.6.5 Details Of Primary Research
• 1.7 Information Or Data Analysis
  • 1.7.1 Data Analysis Models
• 1.8 Market Formulation & Validation
• 1.9 Model Details
  • 1.9.1 Commodity Flow Analysis
• 1.10 List of Secondary Sources
• 1.11 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Summary
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape

Chapter 3 Global Analgesics Market Variables, Trends, & Scope

• 3.1 Analgesics Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
• 3.2 Penetration And Growth Prospect Mapping
• 3.3 Market Driver Analysis
  • 3.3.1 Increasing Prevalence Of Chronic Diseases
  • 3.3.2 Surge In Geriatric Population
  • 3.3.3 Rising Demand For Otc Painkillers
• 3.4 Market Restraint Analysis
  • 3.4.1 Side Effects Associated With Long Term Use Of Analgesics
  • 3.4.2 Rising Abusive Use Of Opoid Analgesics
• 3.5 Porter's Five Forces Analysis
• 3.6 Swot Analysis
• 3.7 Covid-19 Impact Analysis

Chapter 4 Analgesics Market - Segment Analysis, By Drug Type, 2018 - 2030 (USD Million)

• 4.1 Global Analgesics Market: Drug Type Movement Analysis
• 4.2 Opioid
  • 4.2.1 Opioid Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.3 Non-Opioid
  • 4.3.1 Non-Opioid Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.4 Compound Medication
  • 4.4.1 Compound Medication Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Analgesics Market - Segment Analysis, By Route Of Administration, 2018 - 2030 (USD Million)

• 5.1 Global Analgesics Market: Route Of Administration Movement Analysis
• 5.2 Oral
  • 5.2.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.3 Parenteral
  • 5.3.1 Parenteral Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.4 Transdermal
  • 5.4.1 Transdermal Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.5 Others
  • 5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Analgesics Market- Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

• 6.1 Analgesics Market: Distribution Channel Movement Analysis
• 6.2 Hospital Pharmacies
  • 6.2.1 Hospital Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.3 Retail Pharmacies
  • 6.3.1 Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.4 Online Pharmacies
  • 6.4.1 Online Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Analgesics Market- Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 7.1 Analgesics Market: Application Movement Analysis
• 7.2. Musculoskeletal
  • 7.2.1 Musculoskeletal Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.3 Surgical And Trauma
  • 7.3.1 Surgical & Trauma Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.4 Cancer
  • 7.4.1 Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.5 Neuropathic
  • 7.5.1 Neuropathic Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.6 Migraine
  • 7.6.1 Migraine Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.7 Obstetrical
  • 7.7.1 Obstetrical Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.8 Fibromyalgia
  • 7.8.1 Fibromyalgia Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.9 Pain Due To Burns
  • 7.9.1 Pain Due To Burns Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.10 Dental/Facial
  • 7.10.1 Dental/Facial Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.11 Pediatric
  • 7.11.1 Pediatric Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.12 Others
  • 7.12.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Analgesics Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 8.1 Analgesics Market: Regional Movement Analysis
• 8.2 North America
  • 8.2.1 SWOT Analysis
    • 8.2.1.1 North America Analgesics Market, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 Key country dynamics
    • 8.2.2.2 Competitive scenario
    • 8.2.2.3 U.S. analgesics market, 2018 - 2030 (USD Million)
  • 8.2.3 Canada
    • 8.2.3.1 Key country dynamics
    • 8.2.3.2 Competitive scenario
    • 8.2.3.3 Canada analgesics market, 2018 - 2030 (USD Million)
• 8.3 Europe
  • 8.3.1 Swot Analysis
    • 8.3.1.1 Europe Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3.2 UK
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 Competitive Scenario
    • 8.3.2.3 UK Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.3 Germany
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Competitive Scenario
    • 8.3.3.3 Germany Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 Competitive Scenario
    • 8.3.4.3 France Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.5 Italy
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Competitive Scenario
    • 8.3.5.3 Italy Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.6 Spain
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Competitive Scenario
    • 8.3.6.3 Spain Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Competitive Scenario
    • 8.3.7.3 Denmark Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Competitive Scenario
    • 8.3.8.3 Sweden Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Competitive Scenario
    • 8.3.9.3 Norway Analgesics Market, 2018 - 2030 (USD Million)
  • 8.3.10 Rest Of Europe
    • 8.3.10.1 Key Country Dynamics
    • 8.3.10.2 Competitive Scenario
    • 8.3.10.3 Rest Of Europe Analgesics Market, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Swot Analysis
    • 8.4.1.1 Asia Pacific Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 Competitive Scenario
    • 8.4.2.3 Japan Analgesics Market, 2018 - 2030 (USD Million)
  • 8.4.3 China
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 Competitive Scenario
    • 8.4.3.3 China Analgesics Market, 2018 - 2030 (USD Million)
  • 8.4.4 India
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 Competitive Scenario
    • 8.4.4.3 India Analgesics Market, 2018 - 2030 (USD Million)
  • 8.4.5 Australia
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 Competitive Scenario
    • 8.4.5.3 Australia Analgesics Market, 2018 - 2030 (USD Million)
  • 8.4.6 South Korea
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Competitive Scenario
    • 8.4.6.3 South Korea Analgesics Market, 2018 - 2030 (USD Million)
  • 8.4.7 Thailand
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 Competitive Scenario
    • 8.4.7.3 Thailand Analgesics Market, 2018 - 2030 (USD Million)
  • 8.4.8 Rest Of Asia Pacific
    • 8.4.8.1 Key Country Dynamics
    • 8.4.8.2 Competitive Scenario
    • 8.4.8.3 Rest Of Asia Pacific Analgesics Market, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Swot Analysis
    • 8.5.1.1 Latin America Analgesics Market, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Competitive Scenario
    • 8.5.2.3 Brazil Analgesics Market, 2018 - 2030 (USD Million)
  • 8.5.3 Mexico
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Competitive Scenario
    • 8.5.3.3 Mexico Analgesics Market, 2018 - 2030 (USD Million)
  • 8.5.4 Argentina
    • 8.5.4.1 Key Country Dynamics
    • 8.5.4.2 Competitive Scenario
    • 8.5.4.3 Argentina Analgesics Market, 2018 - 2030 (USD Million)
  • 8.5.5 Rest Of Latin America
    • 8.5.5.1 Key Country Dynamics
    • 8.5.5.2 Competitive Scenario
    • 8.5.5.3 Rest Of Latin America Analgesics Market, 2018 - 2030 (USD Million)
• 8.6 Middle East & Africa (MEA)
  • 8.6.1 Swot Analysis
    • 8.6.1.1 Mea Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 Competitive Scenario
    • 8.6.2.3 South Africa Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Competitive Scenario
    • 8.6.3.3 Saudi Arabia Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 Competitive Scenario
    • 8.6.4.3 UAE Analgesics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6.5 Kuwait
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Competitive scenario
    • 8.6.5.3 Kuwait analgesics market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.6 Rest of MEA
    • 8.6.6.1 Key country dynamics
    • 8.6.6.2 Competitive scenario
    • 8.6.6.3 Rest of MEA analgesics estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

• 9.1 Company Profiles
  • 9.1.1 Bayer AG
    • 9.1.1.1 Company overview
    • 9.1.1.2 Financial performance
    • 9.1.1.3 Product benchmarking
    • 9.1.1.4 Strategic Initiatives
  • 9.1.2 Endo International plc
    • 9.1.2.1 Company overview
    • 9.1.2.2 Financial performance
    • 9.1.2.3 Product benchmarking
    • 9.1.2.4 Strategic Initiatives
  • 9.1.3 Assertio Holdings, Inc.
    • 9.1.3.1 Company overview
    • 9.1.3.2 Financial performance
    • 9.1.3.3 Product benchmarking
    • 9.1.3.4 Strategic Initiatives
  • 9.1.4 Janssen Global Services, LLC
    • 9.1.4.1 Company overview
    • 9.1.4.2 Financial performance
    • 9.1.4.3 Product benchmarking
    • 9.1.4.4 Strategic Initiatives
  • 9.1.5 GSK plc
    • 9.1.5.1 Company overview
    • 9.1.5.2 Financial performance
    • 9.1.5.3 Product benchmarking
    • 9.1.5.4 Strategic Initiatives
  • 9.1.6 AbbVie Inc
    • 9.1.6.1 Company overview
    • 9.1.6.2 Financial performance
    • 9.1.6.3 Product benchmarking
    • 9.1.6.4 Strategic Initiatives
  • 9.1.7 Novartis AG
    • 9.1.7.1 Company overview
    • 9.1.7.2 Financial performance
    • 9.1.7.3 Product benchmarking
    • 9.1.7.4 Strategic initiatives
  • 9.1.8 Viatris Inc.
    • 9.1.8.1 Company overview
    • 9.1.8.2 Financial performance
    • 9.1.8.3 Product benchmarking
    • 9.1.8.4 Strategic initiatives
  • 9.1.9 Teva Pharmaceutical Industries Ltd.
    • 9.1.9.1 Company overview
    • 9.1.9.2 Financial performance
    • 9.1.9.3 Product benchmarking
    • 9.1.9.4 Strategic initiatives
• 9.2 Strategy Mapping
  • 9.2.1 Expansions
  • 9.2.2 Acquisitions
  • 9.2.3 Collaborations
  • 9.2.4 Product/service launches
  • 9.2.5 Partnerships
  • 9.2.6 Others
• 9.3 Company Market Share Analysis, 2022
• 9.4 Company Position Analysis, 2022
• 9.5 Market Participant Categorization